24-Hour Results From a Placebo-Controlled Trial, to Evaluate a Novel Peppermint Oil Delivery System, Targeting Release in the Small Intestine. Results From the US Based, 4-Week, Randomized, Placebo Controlled, Multi-Centered Ibsrest™ Trial

被引：0

|

作者：

Epstein, Michael S.

Cash, Brooks D.

Shah, Syed M.

机构：

来源：

GASTROENTEROLOGY | 2015年 / 148卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

314

引用

收藏

页码：S69 / S70

页数：2

相关论文

共 29 条

[1] Ibgard®, a Novel Targeted Delivery System of Peppermint Oil, Results in Significant Improvement in the Total IBS Symptom Score and Individual IBS Symptoms. Results From the US Based, 4-Week, Randomized, Placebo Controlled, Multi-Centered Ibsrest™ Trial
Cash, Brooks D.
Epstein, Michael S.
Shah, Syed M.
[J]. GASTROENTEROLOGY, 2015, 148 (04) : S662 - S663
[2] Ibgard®, a Novel Small Intestine Targeted Delivery System of Peppermint Oil, Results in Significant Improvement in Severe and Unbearable IBS Symptom Intensity. Results From a US Based, 4-Week, Randomized, Placebo-Controlled, Multi-Center Ibsrest™ Trial
Cash, Brooks D.
Epstein, Michael S.
Shah, Syed M.
[J]. GASTROENTEROLOGY, 2015, 148 (04) : S489 - S489
[3] Comparison of 10-hour and 24-hour measurements of fractional calcium absorption (FCA): Results from a randomized, placebo-controlled clinical trial.
Shapses, S. A.
Robson, R.
Kendler, D. L.
Binkley, N. C.
Sherrell, R.
Bayne, W.
Woolf, E.
Berd, Y.
Mantz, A.
Wehren, L.
Liu, M.
Yang, Z.
Santora, A.
[J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 : S418 - S418
[4] Sleep maintenance effect of indiplon in primary insomnia: Results from a double-blind, placebo-controlled, 4-week trial
Klee, B
Lankford, DA
Landin, R
Farber, R
[J]. NEUROLOGY, 2006, 66 (05) : A78 - A78
[5] Treatment of severe Alzheimer's disease with donepezil: Results from a 24-week, multinational, randomized, double-blind, placebo-controlled trial
Black, S
Li, HL
McRae, T
Richardson, S
[J]. NEUROLOGY, 2006, 66 (05) : A347 - A347
[6] Donepezil treatment of severe Alzheimer's disease: Results from a 24-week, multinational, randomized, double-blind, placebo-controlled trial
Black, S.
Li, H.
McRae, T.
Richardson, S.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 69 - 69
[7] Donepezil improves cognition in patients with vascular dementia: Results from study 307, a 24-week, randomized, double-blind, placebo-controlled trial
Roman, GC
Pratt, RD
Perdomo, CA
Perdomo, CA
[J]. NEUROBIOLOGY OF AGING, 2002, 23 (01) : S55 - S55
[8] Donepezil treatment of patients with severe Alzheimer's disease in a Japanese population: Results from a 24-week, double-blind, placebo-controlled, Randomized trial
Homma, Akira
Imai, Yukimichi
Tago, Hisao
Asada, Takashi
Shigeta, Masahiro
Iwamoto, Toshihiko
Takita, Masashi
Arimoto, Itaru
Koma, Hiroshi
Ohbayashi, Toshio
[J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2008, 25 (05) : 399 - 407
[9] Neuropsychiatric symptoms in dementia and the effects of Ginkgo biloba extract EGb 761 (R) treatment: additional results from a 24-week randomized, placebo-controlled trial
Nacu, Anatol
Hoerr, Robert
[J]. OPEN ACCESS JOURNAL OF CLINICAL TRIALS, 2016, 8 : 1 - 6
[10] Donepezil improves cognitive function in patients with vascular dementia: Results from study 307, a 24-week, randomized, double-blind, placebo-controlled trial
Pratt, RD
Perdomo, CA
[J]. NEUROLOGY, 2002, 58 (07) : A161 - A162